We are live on !
Find out more
EntryPoint Capital Portfolio holdings
AUM
$412M
Turnover
50.4%
1-Year Est. Return
28.52%
This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+28.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$412M
AUM Growth
+$70.8M
(+21%)
Cap. Flow
+$36.5M
Cap. Flow % of AUM
Cap. Flow %
8.87%
Top 10 Holdings %
Top 10 Hldgs %
4.34%
Holding
1,002
New
271
Increased
170
Reduced
168
Closed
234
Avg Time Held
0.4
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Huntington Bancshares
HBAN
|
+$1.67M |
| 2 |
Donaldson
DCI
|
+$1.6M |
| 3 |
FedEx
FDX
|
+$1.6M |
| 4 |
Fidelity National Financial
FNF
|
+$1.53M |
| 5 |
Graco
GGG
|
+$1.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$1.48M |
| 2 |
TIC Solutions Inc
TIC
|
+$1.48M |
| 3 |
Schrodinger
SDGR
|
+$1.27M |
| 4 |
Exelon
EXC
|
+$1.23M |
| 5 |
Visteon
VC
|
+$1.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18% |
| 2 | Financials | 16.8% |
| 3 | Healthcare | 15.07% |
| 4 | Technology | 12.86% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
526
Progress Software
PRGS
$1.79B
| $316K | 0.08% |
+9,397
| New | +$278K |
2026 Q2
0 quarters
|
|
527
Carvana
CVNA
$65.1B
| $315K | 0.08% |
+4,793
| New | +$339K |
2026 Q2
0 quarters
|
|
528
SITE Centers
SITC
$195M
| $315K | 0.08% |
+79,322
| New | +$413K |
2026 Q2
0 quarters
|
|
529
Phillips Edison & Co
PECO
$4.8B
| $314K | 0.08% |
7,549
| – | – |
2025 Q4
2 quarters
|
|
530
Ecovyst
ECVT
$1.09B
| $314K | 0.08% |
25,200
+9,820
| +64% | +$133K |
2025 Q4
2 quarters
|
|
531
Brunswick
BC
$4.24B
| $313K | 0.08% |
3,716
| – | – |
2025 Q1
5 quarters
|
|
532
Amphenol
APH
$195B
| $313K | 0.08% |
3,548
-13,682
| -79% | -$986K |
2024 Q4
6 quarters
|
|
533
Third Coast Bancshares
TCBX
$679M
| $313K | 0.08% |
7,736
| – | – |
2025 Q2
4 quarters
|
|
534
Boston Omaha
BOC
$377M
| $313K | 0.08% |
22,913
+2,588
| +13% | +$32.6K |
2023 Q4
10 quarters
|
|
535
Guardant Health
GH
$22.4B
| $313K | 0.08% |
+2,083
| New | +$227K |
2026 Q2
0 quarters
|
|
536
Contango Silver & Gold Inc
CTGO
$502M
| $312K | 0.08% |
+19,773
| New | +$407K |
2026 Q2
0 quarters
|
|
537
Cheniere Energy
LNG
$58.7B
| $311K | 0.08% |
1,303
-42
| -3% | -$10.5K |
2025 Q3
3 quarters
|
|
538
Vera Therapeutics
VERA
$2.25B
| $311K | 0.08% |
+7,245
| New | +$270K |
2026 Q2
0 quarters
|
|
539
Coherent
COHR
$46.8B
| $310K | 0.08% |
786
-756
| -49% | -$267K |
2025 Q3
3 quarters
|
|
540
FIGS
FIGS
$3.32B
| $310K | 0.08% |
+30,273
| New | +$398K |
2026 Q2
0 quarters
|
|
541
Healthcare Services Group
HCSG
$1.49B
| $309K | 0.08% |
12,595
-4,044
| -24% | -$85.4K |
2026 Q1
1 quarter
|
|
542
SmartFinancial
SMBK
$825M
| $308K | 0.07% |
6,570
| – | – |
2025 Q3
3 quarters
|
|
543
Ball Corp
BALL
$17B
| $308K | 0.07% |
4,935
| – | – |
2025 Q2
4 quarters
|
|
544
Apogee Enterprises
APOG
$913M
| $307K | 0.07% |
6,721
-15,432
| -70% | -$576K |
2025 Q3
3 quarters
|
|
545
L3Harris
LHX
$46.1B
| $307K | 0.07% |
+1,055
| New | +$335K |
2026 Q2
0 quarters
|
|
546
Ovintiv
OVV
$19.3B
| $306K | 0.07% |
+5,808
| New | +$332K |
2026 Q2
0 quarters
|
|
547
Napco Security Technologies
NSSC
$1.33B
| $305K | 0.07% |
+8,032
| New | +$319K |
2026 Q2
0 quarters
|
|
548
Lantronix
LTRX
$278M
| $304K | 0.07% |
+51,770
| New | +$332K |
2026 Q2
0 quarters
|
|
549
Novartis
NVS
$293B
| $303K | 0.07% |
+1,936
| New | +$290K |
2026 Q2
0 quarters
|
|
550
Puma Biotechnology
PBYI
$563M
| $303K | 0.07% |
37,386
-16,078
| -30% | -$118K |
2025 Q4
2 quarters
|
|
Similar funds
EntryPoint Capital's Q2 2026 Portfolio in Review
As of Q2 2026, EntryPoint Capital held 1,002 positions worth $412M, up 21% from $341M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.
EntryPoint Capital deployed $36.5M of net new capital in Q2 2026, opening 271 new positions and adding to 170 existing holdings. Its largest new stake was Huntington Bancshares: 101,010 shares worth $1.79M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cadence Design Systems, an estimated $1.48M trimmed.
- EntryPoint Capital's largest Q2 2026 buy was Huntington Bancshares: 101,010 shares worth $1.79M.
- EntryPoint Capital added most to Gilead Sciences in Q2 2026, an estimated $1.51M increase.
- EntryPoint Capital's biggest Q2 2026 reduction was Cadence Design Systems, cutting an estimated $1.48M.
- EntryPoint Capital fully exited Exelon in Q2 2026, selling an estimated $1.23M.
- EntryPoint Capital's ten largest holdings make up 4.3% of its $412M portfolio in Q2 2026.
- EntryPoint Capital opened 271 new positions and closed 234 in Q2 2026.
- EntryPoint Capital's portfolio value rose 21% quarter-over-quarter to $412M.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.